Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PHILADELPHIA-CHROMOSOME' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 814 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Campbell, JDM; Cook, G; Holyoake, TL
      Evolution of bone marrow transplantation - the original immunotherapy

      TRENDS IN IMMUNOLOGY
    2. Dietz, AB; Litzow, MR; Bulur, PA; Vuk-Pavlovic, S
      Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells

      CYTOTHERAPY
    3. Szer, J; Lieschke, GJ
      Small molecule: large hopes

      INTERNAL MEDICINE JOURNAL
    4. Weisberg, E; Griffin, JD
      Mechanisms of resistance imatinib (ST1571) in preclinical models and in leukemia patients

      DRUG RESISTANCE UPDATES
    5. Benthin, M; Dallmann, I; Atzpodien, J
      13cis-and all-trans retinoic acid have antiproliferative effects on CML cells and render IFN alpha antiproliferative potency after combined treatmentin vitro

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    6. Honda, H; Hirai, H
      Model mice for BCR/ABL-positive leukemias

      BLOOD CELLS MOLECULES AND DISEASES
    7. Vigneri, P; Wang, JYJ
      Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase

      NATURE MEDICINE
    8. Fioretos, T; Panagopoulos, I; Lassen, C; Swedin, A; Billstrom, R; Isaksson, M; Strombeck, B; Olofsson, T; Mitelman, F; Johansson, B
      Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: The first fusion gene involving BCR but not ABL

      GENES CHROMOSOMES & CANCER
    9. Jeffs, AR; Wells, E; Morris, CM
      Nonrandom distribution of interspersed repeat elements in the BCR and ABLIgenes and its relation to breakpoint cluster regions

      GENES CHROMOSOMES & CANCER
    10. Clark, RE; Christmas, SE
      BCR-ABL fusion peptides and cytotoxic T cells in chronic myeloid leukaemia

      LEUKEMIA & LYMPHOMA
    11. Lindauer, M; Fischer, T
      Interferon-alpha combined with cytarabine in chronic myelogenous leukemia - Clinical benefits

      LEUKEMIA & LYMPHOMA
    12. Shiratsuchi, M; Muta, K; Minami, R; Motomura, S; Suehiro, Y; Abe, Y; Shiokawa, S; Umemura, T; Fukui, T; Nishimura, J; Nawata, H
      Aberrant BCR-ABL transcript with intronic insertion in a patient with Philadelphia chromosome-positive chronic myeloid leukemia: Implications for disease progression

      LEUKEMIA & LYMPHOMA
    13. Xie, SH; Wang, Y; Liu, JX; Sun, T; Wilson, MB; Smithgall, TE; Arlinghaus, RB
      Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation

      ONCOGENE
    14. Lin, F; Monaco, G; Sun, T; Liu, JX; Lin, H; Stephens, C; Belmont, J; Arlinghaus, RB
      BCR gene expression blocks Bcr-Abl induced pathogenicity in a mouse model

      ONCOGENE
    15. Ko, BS; Tang, JL; Tsai, W; Chen, YC; Wang, CH; Sheng, MC; Lin, DT; Lin, KH; Tien, HF
      Philadelphia chromosome-positive acute lymphoblastic leukemia in Taiwan

      ANNALS OF HEMATOLOGY
    16. Wakayama, T; Maniwa, Y; Ago, H; Kakazu, N; Abe, T
      A variant form of myelodysplastic syndrome with Ph- minor-BCR/ABL transcript

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    17. Maru, Y
      Molecular biology of chronic myeloid leukemia

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    18. Hoeijmakers, JHJ
      From xeroderma pigmentosum to the biological clock contributions of Dirk Bootsma to human genetics

      MUTATION RESEARCH-DNA REPAIR
    19. Wakoff, AR; Porter, DL
      The biology and treatment of chronic myelogenous leukemia - The Brunstein/McGlave article reviewed

      ONCOLOGY-NEW YORK
    20. Bruecher-Encke, B; Griffin, JD; Neel, BG; Lorenz, U
      Role of the tyrosine phosphatase SHP-1 in K562 cell differentiation

      LEUKEMIA
    21. Damiano, JS; Hazlehurst, LA; Dalton, WS
      Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation

      LEUKEMIA
    22. Horibe, K; Tsukimoto, I; Ohno, R
      Clinicopathologic characteristics of leukemia in Japanese children and young adults

      LEUKEMIA
    23. Seiter, K; Feldman, EJ; Sreekantaiah, C; Pozzuoli, M; Weisberger, J; Liu, D; Papageorgio, C; Weiss, M; Kancherla, R; Ahmed, T
      Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy

      LEUKEMIA
    24. Pui, CH; Sailan, S; Relling, MV; Masera, G; Evans, WE
      International childhood Acute Lymphoblastic Leukemia workshop: Sausalito, CA, 30 November-1 December 2000

      LEUKEMIA
    25. Yu, Q; Brain, J; Laneuville, P; Osmond, DG
      Suppressed apoptosis of pre-B cells in bone marrow of pre-leukemic p190(bcr/abl) transgenic mice

      LEUKEMIA
    26. Shteper, PJ; Siegfried, Z; Asimakopoulos, FA; Palumbo, GA; Rachmilewitz, EA; Ben-Neriah, Y; Ben-Yehuda, D
      ABL1 methylation in Ph-positive ALL is exclusively associated with the P210 form of BCR-ABL

      LEUKEMIA
    27. Kawaguchi, Y; Jinnai, I; Nagai, K; Yagasaki, F; Yakata, Y; Matsuo, T; Kuriyama, K; Tomonaga, M
      Effect of a selective Abl tyrosine kinase inhibitor, STI571, on in vitro growth of BCR-ABL-positive acute lymphoblastic leukemia cells

      LEUKEMIA
    28. Tabernero, MD; Bortoluci, AM; Alaejos, I; Lopez-Berges, MC; Rasillo, A; Garcia-Sanz, R; Garcia, M; Sayagues, JM; Gonzalez, M; Mateo, G; San Miguel, JF; Orfao, A
      Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression

      LEUKEMIA
    29. Ferrero, D; Foli, C; Giaretta, F; Argentino, C; Rus, C; Pileri, A
      Growth advantage of chronic myeloid leukemia CFU-GM in vitro: survival to growth factor deprivation, possibly related to autocrine stimulation, is a more common feature than hypersensitivity to GM-CSF/IL3 and is efficiently counteracted by retinoids +/- alpha-interferon

      LEUKEMIA
    30. Miyamoto, N; Sugita, K; Goi, K; Inukai, T; Iijima, K; Tezuka, T; Kojika, S; Nakamura, M; Kagami, K; Nakazawa, S
      The JAK2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 11q23 translocation or Philadelphia chromosome

      LEUKEMIA
    31. Kramer, A; Loffler, H; Bergmann, J; Hochhaus, A; Hehlmann, R
      Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia

      LEUKEMIA
    32. Kurzrock, R; Bueso-Ramos, CE; Kantarjian, H; Freireich, E; Tucker, SL; Siciliano, M; Pilat, S; Talpaz, M
      BCR rearrangement-negative chronic myelogenous leukemia revisited

      JOURNAL OF CLINICAL ONCOLOGY
    33. Wu, JH; Suzuki, H; Zhou, YW; Liu, W; Yoshihara, M; Kato, M; Akhand, AA; Hayakawa, A; Takeuchi, K; Hossain, K; Kurosawa, M; Nakashima, I
      Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell lines

      JOURNAL OF CELLULAR BIOCHEMISTRY
    34. Zanella, I; Rossi, G; Finazzi, D; Capucci, A; Albertini, A; Cariani, E
      Quantification of bcr/abl mRNA expression by a rapid real time reverse transcription-polymerase chain reaction assay in patients with chronic myeloidleukemia

      HAEMATOLOGICA
    35. Marin, C; Martinez-Delgado, B; Melendez, B; Larrayoz, MJ; Martinez-Ramirez, A; Robledo, M; Cigudosa, JC; Calasanz, MJ; Benitez, J
      Multiplex-polymerase chain reaction assay for the detection of prognostically significant translocations in acute lymphoblastic leukemia

      HAEMATOLOGICA
    36. Kudoh, T; Suzuki, N; Hatakeyama, N; Mizue, N; Hori, T; Oda, T; Watanabe, J; Imamura, M; Chiba, S
      Successful unrelated cord blood transplantation in Philadelphia chromosomepositive acute lymphoblastic leukemia during pulmonary aspergillosis treated by anti-fungal therapy, granulocyte colony-stimulating factor-mobilized granulocytes and surgical resection: Case report

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    37. Fan, EJ; Ying, H; Zhao, CH
      Human stem cell model to study signal transduction and molecular regulation mechanisms in CML

      CHINESE MEDICAL JOURNAL
    38. Dietz, AB; Litzow, MR; Gastineau, DA; Vuk-Pavlovic, S
      Engineering dendritic cell grafts for clinical trials in cellular immunotherapy of cancer: Example of chronic myelogenous leukemia

      CROATIAN MEDICAL JOURNAL
    39. Hicks, C; Keoshkerian, E; Gaudry, L; Lindeman, R
      CD80 (B7-1) expression on human acute myeloid leukaemic cells cultured with GM-CSF, IL-3 and IL-6

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    40. He, L; Feng, HP; Raymond, A; Kreeger, M; Zeng, Y; Graner, M; Whitesell, L; Katsanis, E
      Dendritic-cell-peptide immunization provides immunoprotection against bcr-abl-positive leukemia in mice

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    41. Daheron, L; Zenz, T; Siracusa, LD; Brenner, C; Calabretta, B
      Molecular cloning of Ian4: a BCR/ABL-induced gene that encodes an outer membrane mitochondrial protein with GTP-binding activity

      NUCLEIC ACIDS RESEARCH
    42. Buchdunger, E; Matter, A; Druker, BJ
      Bcr-Abl inhibition as a modality of CML therapeutics

      BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
    43. Jorgensen, HG; Holyoake, TL
      A comparison of normal and leukemic stem cell biology in chronic myeloid leukemia

      HEMATOLOGICAL ONCOLOGY
    44. Zhang, ZW; Subrahmanyam, R; Wong, R; Gross, AW; Ren, RB
      The NH2-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl

      MOLECULAR AND CELLULAR BIOLOGY
    45. Drummond, MW; Holyoake, TL
      Tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia: so far so good?

      BLOOD REVIEWS
    46. Maury, S; Belhadj, K; Chami, I; Kuentz, M; Cordonnier, C; Bories, D
      Autologous reconstitution combined with durable leukemic remission after allogeneic BMT for CML: absence of persistence of a donor-derived T cell effector population

      BONE MARROW TRANSPLANTATION
    47. Mahon, FX
      Chronic myelogenous leukemic and tyrosine kinase inhibitors.

      REVUE DE MEDECINE INTERNE
    48. Thiele, J; Kvasnicka, HM; Beelen, DW; Leder, LD; Schaefer, UW
      Bone marrow engraftment: histopathology of hematopoietic reconstitution following allogeneic transplantation in CML patients

      HISTOLOGY AND HISTOPATHOLOGY
    49. Tanaka, K; Minamihisamatu, M; Yagi, S; Kyo, T; Dohy, H; Kamada, N
      Two step mechanism for formation of complex 9;22 chromosome translocation in chronic myelocytic leukemia detected by fluorescence in situ hybridization

      EXPERIMENTAL ONCOLOGY
    50. Gonzalez, FA; Anguita, E; Mora, A; Asenjo, S; Lopez, I; Polo, M; Villegas, A
      Deletion of BCR region 3 ' in chronic myelogenous leukemia

      CANCER GENETICS AND CYTOGENETICS
    51. Mohr, B; Bornhauser, M; Platzbecker, U; Freiberg-Richter, J; Naumann, R; Prange-Krex, G; Mohm, J; Kroschinsky, F; Ehninger, G; Thiede, C
      Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals

      CANCER GENETICS AND CYTOGENETICS
    52. Ge, XQ; Tanaka, K; Mansyur, A; Tazawa, H; Iwato, K; Kyo, T; Dohy, H; Kamada, N
      Possible prediction of myeloid and lymphoid crises in chronic myelocytic leukemia at onset by determining the methylation status of the major breakpoint cluster region

      CANCER GENETICS AND CYTOGENETICS
    53. Naumann, S; Reutzel, D; Speicher, M; Decker, HJ
      Complete karyotype characterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization

      LEUKEMIA RESEARCH
    54. Mori, T; Manabe, A; Tsuchida, M; Hanada, R; Yabe, H; Ohara, A; Saito, T; Nakazawa, S
      Allogeneic bone marrow transplantation in first remission rescues childrenwith Philadelphia chromosome-positive acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) studies L89-12 and L92-13

      MEDICAL AND PEDIATRIC ONCOLOGY
    55. McCabe, MG; Broadbent, V; Williams, DM
      Unusual cause of extradural haemorrhage

      MEDICAL AND PEDIATRIC ONCOLOGY
    56. Oudat, R; Khan, Z; Glassman, AB
      Detection of trisomy 8 in Philadelphia chromosome-positive CML patients using conventional cytogenetic and interphase fluorescence in situ hybridization techniques and its relation to c-myc involvement

      ANNALS OF CLINICAL AND LABORATORY SCIENCE
    57. Witte, O
      The role of Bcr-Abl in chronic myeloid leukemia and stem cell biology

      SEMINARS IN HEMATOLOGY
    58. Gorre, ME; Mohammed, M; Ellwood, K; Hsu, N; Paquette, R; Rao, PN; Sawyers, CL
      Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

      SCIENCE
    59. Dai, ZH; Kerzic, P; Schroeder, WG; McNiece, IK
      Deletion of the Src homology 3 domain and C-terminal proline-rich sequences in Bcr-Abl prevents Abl interactor 2 degradation and spontaneous cell migration and impairs leukemogenesis

      JOURNAL OF BIOLOGICAL CHEMISTRY
    60. Parada, Y; Banerji, L; Glassford, J; Lea, NC; Collado, M; Rivas, C; Lewis, JL; Gordon, MY; Thomas, NSB; Lam, EWF
      BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27(Kip1) expression

      JOURNAL OF BIOLOGICAL CHEMISTRY
    61. Kain, KH; Klemke, RL
      Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes

      JOURNAL OF BIOLOGICAL CHEMISTRY
    62. Deininger, MWN; Vieira, SAD; Parada, Y; Banerji, L; Lam, EWF; Peters, G; Mahon, FX; Kohler, T; Goldman, JM; Melo, JV
      Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts

      CANCER RESEARCH
    63. Goetz, AW; van der Kuip, H; Maya, R; Oren, M; Aulitzky, WE
      Requirement for Mdm2 in the survival effects of Bcr-Abl and interleukin 3 in hematopoietic cells

      CANCER RESEARCH
    64. Wang, Y; Liu, JX; Wu, Y; Luo, WP; Lin, SH; Lin, H; Hawk, N; Sun, T; Guo, JQ; Estrov, Z; Talpaz, M; Champlin, R; Arlinghaus, RB
      Expression of a truncated first exon BCR sequence in chronic myelogenous leukemia cells blocks cell growth and induces cell death

      CANCER RESEARCH
    65. Etienne, G; Mahon, FX
      Leukemogenesis and new therapy development: the example of chronic myelogenous leukemia

      BULLETIN DU CANCER
    66. Donadieu, J; Hill, C
      Early response to chemotherapy as a prognostic factor in childhood acute lymphoblastic leukaemia: a methodological review

      BRITISH JOURNAL OF HAEMATOLOGY
    67. Sica, S; Chiusolo, P; Zollino, M; Sora, F; Piccirillo, N; Laurenti, L; Reddiconto, G; Leone, G
      The association of severe aplastic anaemia with the Philadelphia chromosome and the BCR/ABL transcript

      BRITISH JOURNAL OF HAEMATOLOGY
    68. Holyoake, TL
      Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: Lessons to be learned from the laboratory

      BRITISH JOURNAL OF HAEMATOLOGY
    69. Ramakers-van Woerden, NL; Pieters, R; Slater, RM; Loonen, AH; Beverloo, HB; van Drunen, E; Heyman, M; Moreno, TC; Rots, MG; van Wering, ER; Kamps, WA; Janka-Schaub, GE; Veerman, AJP
      In vitro drug resistance and prognostic impact of p16(INK4A)/p15(INK4B) deletions in childhood T-cell acute lymphoblastic leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    70. van der Kuip, H; Goetz, AW; Miething, C; Duyster, J; Aulitzky, WE
      Adhesion to fibronectin selectively protects Bcr-Abl(+) cells from DNA damage-induced apoptosis

      BLOOD
    71. Clark, RE; Dodi, IA; Hill, SC; Lill, JR; Aubert, G; Macintyre, AR; Rojas, J; Bourdon, A; Bonner, PLR; Wang, LH; Christmas, SE; Travers, PJ; Creaser, CS; Rees, RC; Madrigal, JA
      Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein

      BLOOD
    72. Zhao, RC; Jiang, YH; Verfaillie, CM
      A model of human p210(bcr/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR/ABL-containing retroviral vector

      BLOOD
    73. Kano, Y; Akutsu, M; Tsunoda, S; Mano, H; Sato, Y; Honma, Y; Furukawa, Y
      In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents

      BLOOD
    74. Sun, XM; Layton, JE; Elefanty, A; Lieschke, GJ
      Comparison of effects of the tyrosine kinase inhibitors AG957, AG490, and STI571 on BCR-ABL-expressing cells, demonstrating synergy between AG490 andSTI571

      BLOOD
    75. Peters, DG; Hoover, RR; Gerlach, MJ; Koh, EY; Zhang, HY; Choe, K; Kirschmeier, P; Bishop, WR; Daley, GQ
      Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia

      BLOOD
    76. Tomasson, MH; Williams, IR; Li, SG; Kutok, J; Cain, D; Gillessen, S; Dranoff, G; Van Etten, RA; Gilliland, DG
      Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factoror interleukin-3

      BLOOD
    77. Zhang, XW; Wong, R; Hao, SX; Pear, WS; Ren, RB
      The SH2 domain of Bcr-Abl is not required to induce a murine myeloproliferative disease; however, SH2 signaling influences disease latency and phenotype

      BLOOD
    78. Sun, T; Campbell, M; Gordon, W; Arlinghaus, RB
      Preparation and application of antibodies to phosphoamino acid sequences

      BIOPOLYMERS
    79. Suzuki, R; Takemura, K; Tsutsumi, M; Nakamura, S; Hamajima, N; Seto, M
      Detection of cyclin D1 overexpression by real-time reverse-transcriptase-mediated quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma

      AMERICAN JOURNAL OF PATHOLOGY
    80. Stocks, MR; Rabbitts, TH
      Masked antisense: a molecular configuration for discriminating similar RNAtargets

      EMBO REPORTS
    81. Snyder, DS
      Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    82. Salesse, S; Lagarde, V; Ged, C; De Verneuil, H; Reiffers, J; Mahon, FX
      Retroviral coexpression of IFN-alpha and IFN-gamma genes and inhibitory effects in chronic myeloid leukemia cells

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    83. Fajkusova, L; Fajkus, J; Polackova, K; Fulnecek, J; Dvorakova, D; Kahulcova, E
      Detailed mapping of methylcytosine positions at the CpG island surroundingthe Pa promoter at the bcr-abl locus in CML patients and in two cell lines, K562 and BV173

      BLOOD CELLS MOLECULES AND DISEASES
    84. Svingen, PA; Tefferi, A; Kottke, TJ; Kaur, G; Narayanan, VL; Sausville, EA; Kaufmann, SH
      Effect of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro

      CLINICAL CANCER RESEARCH
    85. Buckle, AM; Mottram, R; Pierce, A; Lucas, GS; Russell, N; Miyan, JA; Whetton, AD
      The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells

      MOLECULAR MEDICINE
    86. Kabarowski, JHS; Witte, ON
      Consequences of BCR-ABL expression within the hematopoietic stem cell in chronic myeloid leukemia

      STEM CELLS
    87. Colleoni, GWB; Jhanwar, SC; Ladanyi, M; Chen, BY
      Comparison of a multiplex reverse transcriptase-polymerase chain reaction for BCR-ABL to fluorescence in situ hybridization, southern blotting, and conventional cytogenetics in the monitoring of patients with Ph1-positive leukemias

      DIAGNOSTIC MOLECULAR PATHOLOGY
    88. Pagano, L; Pulsoni, A; Mele, L; Leone, G
      Clinical and epidemiological features of acute lymphoblastic leukemia following a previous malignancy

      LEUKEMIA & LYMPHOMA
    89. Guinn, BA; Evely, RS; Walsh, V; Gilkes, AF; Burnett, AK; Mills, KI
      An in vivo and in vitro comparison of the effects of b2-a2 and b3-a2 p210BCR-ABL splice variants on murine 32D cells

      LEUKEMIA & LYMPHOMA
    90. Faderl, S; Kantarjian, HM; Thomas, DA; Cortes, J; Giles, F; Pierce, S; Albitar, M; Estrov, Z
      Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia

      LEUKEMIA & LYMPHOMA
    91. Warashina, M; Kuwabara, T; Taira, K
      Working at the cutting edge: the creation of allosteric ribozymes

      STRUCTURE
    92. Salloukh, HF; Vowles, I; Heisterkamp, N; Groffen, J; Laneuville, P
      Early events in leukemogenesis in P190Bcr-abl transgenic mice

      ONCOGENE
    93. Nieborowska-Skorska, M; Slupianek, A; Skorski, T
      Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells

      ONCOGENE
    94. Carayol, G; Giron-Michel, J; Azzarone, B; Castagna, L; Cambier, N; Mishal, Z; Bourhis, JH; Chouaib, S; Caignard, A
      Altered natural killer cell differentiation in CD34(+) progenitors from chronic myeloid leukemia patients

      ONCOGENE
    95. Elmaagacli, AH; Beelen, DW; Opalka, B; Seeber, S; Schafer, UW
      The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage

      ANNALS OF HEMATOLOGY
    96. Nakamura, H; Inokuchi, K; Hanawa, H; Yamaguchi, H; Tamura, H; Tajika, K; Dan, K
      A case of chronic myeloid leukemia with minor bcr-abl transcript followingfluorouracil therapy for esophageal carcinoma

      ANNALS OF HEMATOLOGY
    97. Miura, I; Takahashi, N; Kobayashi, Y; Saito, K; Miura, AB
      Molecular cytogenetics of stem cells: Target cells of chromosome aberrations as revealed by the application of fluorescence in situ hybridization to fluorescence-activated cell sorting

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    98. Nawata, R; Shinohara, K; Yamada, T; Takahashi, T; Katsuki, K; Takeda, K; Kameda, N; Ariyoshi, K; Ota, I; Muraki, K
      Morphological and cytogenetic changes in therapy-related leukemia developed in a t(8;21)-acute myeloid leukemia (M2) patient: Sequential cytogenetic and molecular analyses

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    99. van den Berg, H; van der Lelie, J
      Acute lymphoblastic leukaemia in puberty and adolescence

      ANNALS OF ONCOLOGY
    100. Andreasson, P; Hoglund, M; Bekassy, AN; Garwicz, S; Heldrup, J; Mitelman, F; Johansson, B
      Cytogenetic and FISH studies of a single center consecutive series of 152 childhood acute lymphoblastic leukemias

      EUROPEAN JOURNAL OF HAEMATOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/21 alle ore 07:39:31